Intestinal absorption and bioavailability of traditional Chinese medicines: A review of recent experimental progress and implication for quality control

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 5, 2013, Pages 621-633

  Liu, Jing Yi ^a   Lee, Kai Fai ^b   Sze, Cho Wing ^a   Tong, Yao ^a   Tang, Sydney Chi Wai ^c   Ng, Tzi Bun ^d   Zhang, Yan Bo ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

bioavailability; herbal interactions; intestinal absorption; quality control; traditional Chinese medicine

Indexed keywords

ACONITINE; AURANTIIN; BAICALEIN; BAICALIN; BORNEOL; CHINESE DRUG; CINNAMIC ACID; COUMARIN DERIVATIVE; CRYPTOTANSHINONE; CURCUMIN; FERULIC ACID; GASTRODIN; HESPERIDIN; HONOKIOL; HYPACONITINE; MESACONITINE; OROXYLIN A; PAEONIFLORIN; PEONOL; PIPERINE; SAIKOSAPONIN A; SAIKOSAPONIN D; SALVIANOLIC ACID B; SINOMENINE; TANSHINONE; TANSHINONE IIA; TETRAMETHYLPYRAZINE; TURMERONE; UNINDEXED DRUG; WOGONIN;

BIOLOGICAL MODEL; CHINESE MEDICINE; COMPUTER MODEL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; DRUG SAFETY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE FUNCTION; NONHUMAN; PHYSICAL CHEMISTRY; PREDICTION; QUALITY CONTROL; REVIEW; SMALL INTESTINE;

ANIMALS; BIOLOGICAL AVAILABILITY; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; HUMANS; INTESTINAL ABSORPTION; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; QUALITY CONTROL; RESEARCH;

EID: 84876466708     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01608.x     Document Type: Review

References (102)

1. Farnsworth N, et al. Medicinal plants in therapy. Bull World Health Organ 1985; 63: 965-981.
2. Zheng LW, et al. Traditional Chinese medicine and oral diseases: today and tomorrow. Oral Dis 2011; 17: 7-12.
3. Chan K,. Chinese medicinal materials and their interface with Western medical concepts. J Ethnopharmacol 2005; 96: 1-18.
4. Zhang YC, et al. Study on the application of intestinal absorption in vitro coupled with bioactivity assessment in Yuanhu Zhitong preparation. J Med Plants Res 2012; 6: 1941-1947.
5. Williamson EM,. Synergy and other interactions in phytomedicines. Phytomedicines 2001; 8: 401-409.
6. Qi LW, et al. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 2011; 28: 467-495.
7. Liang XM, et al. Qualitative and quantitative analysis in quality control of traditional Chinese medicines. J Chromatogr A 2009; 1216: 2033-2044.
8. Artursson P, Karlsson J,. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991; 175: 880-885.
9. Li YX, et al. Assessment and modulation of forsythiaside absorption with MDCKII cells and validation with in situ intestinal experiment. Eur J Drug Metab Pharmacokinet 2012; 37: 179-186.
10. Fagerholm U,. Prediction of human pharmacokinetics-gastrointestinal absorption. J Pharm Pharmacol 2007; 59: 905-916.
11. Tukker JJ, et al. Characterization of transport over epithelial barriers. In:, Lehr CM, ed. Cell Culture Models of Biological Barriers. In-Vitro Test Systems for Drug Absorption and Delivery. London: Taylor and Francis, 2002: 52-61.
12. Suzuki H, Sugiyama Y,. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci 2000; 12: 3-12.
13. Akao T, et al. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000; 52: 1563-1568.
14. Ribnicky DM, et al. Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L. Int J Pharm 2009; 370: 87-92.
15. Wang L, et al. A bio-activity guided in vitro pharmacokinetic method to improve the quality control of Chinese medicines, application to Si Wu Tang. Int J Pharm 2011; 406: 99-105.
16. Glaeser H, Fromm MF,. Animal models and intestinal drug transport. Expert Opin Drug Metab Toxicol 2008; 4: 347-361.
17. Alvarez AI, et al. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice. Drug Metab Dispos 2011; 39: 2008-2012.
18. Alam MA, et al. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol 2012; 64: 326-336.
19. Liu W, et al. Sensitive and robust UPLC-MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronide. J Pharm Biomed Anal 2011; 54: 1157-1162.
20. Tanimoto Y, et al. Species difference in metabolism of strychnine with liver microsomes of mice, rats, guinea pigs, rabbits and dogs. J Pharmacobiodyn 1990; 13: 136-141.
21. Jin J, et al. A study of the pharmacokinetics of andrograpolide sodium bisulphite in beagle dogs. Herald Med 2005; 24: 109-111.
22. Wang B, et al. Pharmacokinetics of andrograpolide in rabbits by chemiluminescence method. J Shenyang Pharm Univ 1995; 1: 5-7.
23. Yang X, et al. Establishment of Caco-2 cell monolayer model and standard operation procedure for assessing intestinal absorption of chemical components of traditional Chinese medicine. Zhong Xi Yi Jie He Xue Bao 2007; 5: 634-641.
24. Wu AG, et al. The absorption and transport of magnolol in Caco-2 cell model. Chin J Integr Med 2012; (epub ahead of print).
25. van Breemen RB, Li Y,. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol 2005; 1: 175-185.
26. Lai SK, et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009; 61: 158-171.
27. Liang XL, et al. The absorption characterization effects and mechanism of Radix Angelicae dahuricae extracts on baicalin in Radix Scutellariae using in vivo and in vitro absorption models. J Ethnopharmacol 2012; 139: 52-57.
28. Zhou W, et al. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. Acta Pharmacol Sin 2012; 33: 1069-1079.
29. Volpe DA,. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines. Future Med Chem 2011; 3: 2063-2077.
30. Linnankoski J, et al. Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models. J Pharm Sci 2010; 99: 2166-2175.
31. Fliszar KA, et al. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model. J Pharm Sci 2007; 96: 2161-2170.
32. Matsson P, et al. Exploring the role of different drug transport routes in permeability screening. J Med Chem 2005; 48: 604-613.
33. Tavelin S, et al. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers. Pharm Res 2003; 20: 397-405.
34. Ma BL, et al. Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption. Drug Metab Dispos 2012; 40: 381-388.
35. Moda TL, Andricopulo AD,. Consensus hologram QSAR modeling for the prediction of human intestinal absorption. Bioorg Med Chem Lett 2012; 22: 2889-2893.
36. Akamatsu M, et al. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability. Chem Biodivers 2009; 6: 1845-1866.
37. Hou T, et al. Recent developments of in silico predictions of intestinal absorption and oral bioavailability. Comb Chem High Throughput Screen 2009; 12: 497-506.
38. Parrott N, Lave T,. Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. Eur J Pharm Sci 2002; 17: 51-61.
39. Xu F, et al. Absorption and metabolism of Astragali radix decoction: in silico, in vitro, and a case study in vivo. Drug Metab Dispos 2006; 34: 913-924.
40. Schutte ME, et al. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6- phenylimidazo [4,5-b]pyridine (PhIP) through Caco-2 monolayers. Toxicol Appl Pharmacol 2006; 217: 204-215.
41. Liu ZJ, et al. Intestinal permeability of forskolin by in situ single pass perfusion in rats. Planta Med 2012; 78: 698-702.
42. Chen G, et al. In vitro stability of gentiamarin. Fudan Univ J Med Sci 2008; 35: 220-223.
43. Wright S,. Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics. Toxicol Appl Pharmacol 2005; 204: 309-319.
44. Koepsell H, et al. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007; 24: 1227-1251.
45. Wu Q, et al. Intestinal permeability of sesquiterpenes in the caco-2 cell monolayer model. Planta Med 2010; 76: 319-324.
46. Cao J, et al. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra. Drug Metab Dispos 2007; 35: 539-553.
47. Yu XY, et al. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Curr Drug Metab 2007; 8: 325-340.
48. Zhang X, et al. Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein. Xenobiotica 2011; 41: 290-296.
49. Schellens JH, et al. Modulation of oral bioavailability of anticancer drugs: from mouse to man. Eur J Pharm Sci 2000; 12: 103-110.
50. Richard A, et al. Efflux of dietary flavonoid quercetin 4′-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther 2000; 294: 830-836.
51. Zhang H, Ping Q,. Effects of drug transporters on intestinal absorption of breviscapine. J Chin Pharm Univ 2007; 38: 60-64.
52. Shukla S, et al. Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm Res 2009; 26: 480-487.
53. Zhang S, et al. Structure activity relationships and quantitative structure activity relationships for the flavonoid-meditaed by breast cancer resistance protein. Biochem Pharmacol 2005; 70: 627-639.
54. A.V. D. Drug permeability studies in regulatory biowaver applications. In:, Ehrhardt C, Kim KJ, eds. Drug Absorption Studies. Dublin: New York, NY: Springer Science+Business Media, 2008: 666.
55. Yu K, et al. Absorption, disposition, and pharmacokinetics of saponins from chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab 2012; 13: 577-598.
56. Ruan L, et al. The relationship between the intestinal absorption and in vivo activity of genistein. Chin J Nat Med 2006; 4: 278-282.
57. Li GD, et al. Study on the preparation and dissolution of the sustained release solid dispersions of Artemisinin. Pharm J Chin People's Liberation Army 2000; 16: 15-17.
58. Zheng X, et al. Advances in the study of Chinese herbal drug dripping pills. Zhongguo Zhong Yao Za Zhi 2003; 28: 292-295.
59. Wei X, et al. Study on dry granulation technique for shuanghuanglian effervescent tablets. Chin J Exp Traditional Med Formulae 2010; 11: 1-5.
60. Luan L, et al. Studies on the preparation of camptothecin niosomes. Acta Pharm Sin 2002; 1: 59-62.
61. Li B,. Preparation method of an enteric coated aconitine rapid-release tablet CN Patent:1903181A 2007.01.31.
62. Cai Z, et al. Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target 2008; 16: 178-184.
63. Xiao Y,. Mechanism study on the combinational use of borneol and ligustrazine and the preparation of slow-release capsules of their prescription. Nanjing: China Pharmaceutical University, 2007 (dissertation).
64. Li L, et al. Absorption mechanism of liposoluble components of Salvia miltiorrhiza with Caco-2 cell model. Chin Pharma J 2006; 41: 108-111 [in Chinese].
65. Ping QN,. Gastrointestinal Transport and Dosage Form Design of Chinese Medicine Ingredients, 1st edn. Beijing: Chemical Industry Press, 2010: 174-175.
66. Li N, et al. Intestinal transport of pure diester-type alkaloids from an aconite extract across the Caco-2 cell monolayer model. Planta Med 2012; 78: 692-697.
67. Yue GG, et al. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food 2012; 15: 242-252.
68. Kim Y, et al. Pharmacokinetics of baicalein, baicalin and wogonin after oral administration of a standardized extract of Scutellaria baicalensis, PF-2405 in rats. Arch Pharm Res 2007; 30: 260-265.
69. Li CR, et al. Pharmacokinetic interactions among major bioactive components in radix scutellariae via metabolic competition. Biopharm Drug Dispos 2012; (epub ahead of print).
70. Song M, et al. Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat. Eur J Pharm Sci 2007; 32: 247-253.
71. Lai XJ, et al. Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats. Fitoterapia 2011; 82: 883-888.
72. Chen Y, et al. Interaction of the main components from the traditional Chinese drug pair Chaihu-Shaoyao based on rat intestinal absorption. Molecules 2011; 16: 9600-9610.
73. Chen Y, et al. Pharmacokinetics and bioavailability of cinnamic acid after oral administration of Ramulus Cinnamomi in rats. Eur J Drug Metab Pharmacokinet 2009; 34: 51-56.
74. Xiao Y,. Mechanism study on the combinational use of borneol and ligustrazine and the preparation of slow-release capsules of their prescription. Nanjing: China Pharmaceutical University, 2007 (dissertation).
75. Yang ZY, et al. Study on relative bioavailability of ferulic acid of combination Radix Angelicae Sinensis and Cortex Cinnamonmi in mice. Chin J Chin Mater Med 2006; 32: 1012-1015 [in Chinese].
76. Chan K, et al. The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol 2006; 103: 425-432.
77. Shoba G, et al. Influence of piperine on the pharmacokinetcs of curcumin in animals and human volunteers. Planta Med 1998; 64: 353-356.
78. Wang B, et al. The comparion study on the absorption and metabolism of paeonol in Cortex moutan and Cynanchum. J Xi'an Med Univ 1995; 16: 47-49 [in Chinese].
79. Gong HL, et al. Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction in rats. Chin J Integr Med 2012; 18: 708-713.
80. Liu J, et al. Comparative pharmacokinetics of paeoniflorin in plasma of vascular dementia and normal rats orally administrated with Danggui-Shaoyao-San or pure paeoniflorin. Fitoterapia 2011; 82: 466-473.
81. Wang W, et al. The effect of Acorus gramineus on the bioavailabilities and brain concentrations of ginsenosides Rg1, Re and Rb1 after oral administration of Kai-Xin-San preparations in rats. J Ethnopharmacol 2010; 131: 313-320.
82. Wu H, et al. Comparative pharmacokinetic study of paeoniflorin after oral administration of pure paeoniflorin, extract of Cortex Moutan and Shuang-Dan prescription to rats. J Ethnopharmacol 2009; 125: 444-449.
83. Su WJ, et al. Comparison of pharmacokinetics of honokiol in Magnolia officinalis and Houpu Sanwu Tang after intragastric administration in rats. J Chin Med Mater 2008; 59: 115-121 [in Chinese].
84. Xu M, et al. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats. J Ethnopharmacol 2008; 115: 483-488.
85. Su X, et al. A comparative study of the pharmacokinetics of aristolochic acid a in Longdanxiegan Pills and Caulis Aristolochiae manshuriensis in rats. Herald Med 2005; 2: 116-118 [in Chinese].
86. He FY, et al. Determination of astragaloside ? in rat plasma after the treatment Buyang Huanwu decoction by RP-HPLC and its harmacokinetics. Chin Pharm J 2005; 40: 1647-1649 [in Chinese].
87. Yao SK, et al. Pharmacokinetics of emodin in Polygonum cuspidatum and its prescription in rats. Chin J Chin Mater Med 2005; 30: 463-465 [in Chinese].
88. Lu XH, et al. RP-HPLC in plasma and study on its pharmacokinetics in mice. Chin J Pharm Anal 2004; 2: 140-143 [in Chinese].
89. Xie YS, et al. Influence of different composition of Liuwei Dihuang Tang on the pharmacokinetics of loganin. Chin J Coal Ind Med 2004; 7: 779-780.
90. Zuo F, et al. Pharmacokinetic study on the multi-constituents of Huangqin-Tang decoction in rats. Biol Pharm Bull 2003; 26: 911-919.
91. Zou JM, et al. Pharmacokinetics of icariin in Chinese medicine prescriptions. Chin Traditional Herbal Drugs 2002; 33: 55-58 [in Chinese].
92. Wang Y,. Research progress on the absorption and pharmacokinetics of baicalin. Chin J Curr Pract Med 2005; 4: 44-45 [in Chinese].
93. Wang X, et al. Pharmacokinetics of baicalin in Xiaochaihu Tang in rats. Traditional Chin Drug Res Clin Pharmacol 2001; 12: 84-88.
94. Debelle FD, et al. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74: 158-169.
95. Sun H, et al. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol 2008; 4: 395-411.
96. Kwok KY, Tummala VMR,. A quality control and improvement system based on the total control methodology (TCM). Int J Qual Reliab Manage 1998; 15: 13-48.
97. Wu H, et al. Comparative study on absorption kinetics in intestines of rats of epimedii foliunm of Xianlinggubao capsules prepared by different processes. Zhongguo Zhong Yao Za Zhi 2011; 36: 2648-2652.
98. Chiou WL,. The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharm Drug Dispos 1995; 16: 71-75.
99. Dai JY, et al. Transport and metabolism of flavonoids from Chinese herbal remedy Xiaochaihu- tang across human intestinal Caco-2 cell monolayers. Acta Pharmacol Sin 2008; 29: 1086-1093.
100. Yan L, et al. Study on transportation of Xiaochaihu Tang in Caco-2 cell model. Zhongguo Zhong yao za zhi 2011; 36: 1087-1090.
101. Chen CY,. TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS ONE 2011; 6: e15939.
102. Press B, Di Grandi D,. Permeability for intestinal absorption: Caco-2 assay and related issues. Curr Drug Metab 2008; 9: 893-900.